Supplementary Data 2 from Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction AdenocarcinomaZhi Peng, Lin Shen, Wei Jia et al.|Unknown|2023Cited by 0
Supplementary Data 1 from Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction AdenocarcinomaZhi Peng, Lin Shen, Wei Jia et al.|Unknown|2023Cited by 0
Data from Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction AdenocarcinomaZhi Peng, Lin Shen, Yanqiao Zhang et al.|Unknown|2023Cited by 0
Data from Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction AdenocarcinomaZhi Peng, Lin Shen, Wei Jia et al.|Unknown|2023Cited by 0
Supplementary Data 1 from Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction AdenocarcinomaZhi Peng, Lin Shen, Wei Jia et al.|Unknown|2023Cited by 0